Contact this trialFirst, we need to learn more about you.
Tyrosine Kinase Inhibitor
Osimertinib + Tegavivint for Lung Cancer
Recruiting1 awardPhase 1
Columbus, Ohio
This trial is to find out the benefits and side effects of two drugs, osimertinib and tegavivint, in treating patients with lung cancer that has spread to other places in the body.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.